S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

LPTX Leap Therapeutics Inc

0.5037

-0.0043 (-0.85%)

Feb 14 2025 - Closed

Delayed by 15 minutes

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Leap Therapeutics (NASDAQ:LPTX)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Leap Therapeutics Charts.

Leap Therapeutics (NASDAQ:LPTX)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Leap Therapeutics Charts.

Leap Therapeutics Inc News

Form 8-K - Current report
Tuesday 28 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Leap Therapeutics Reports Initial Clinical Data from Part B of the DeFianCe Study and Part C of the DisTinGuish Study
Tuesday 28 January 2025 (3 weeks ago) • PR Newswire (US)

Leap Therapeutics to Participate at the 43rd Annual J.P. Morgan Healthcare Conference
Monday 6 January 2025 (1 month ago) • PR Newswire (US)

Leap Therapeutics to Participate at Piper Sandler 36th Annual Healthcare Conference
Tuesday 26 November 2024 (3 months ago) • PR Newswire (US)

Form 8-K - Current report
Wednesday 13 November 2024 (3 months ago) • Edgar (US Regulatory)

Leap Therapeutics Reports Third Quarter 2024 Financial Results
Wednesday 13 November 2024 (3 months ago) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 13 November 2024 (3 months ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Wednesday 6 November 2024 (3 months ago) • Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Thursday 31 October 2024 (4 months ago) • Edgar (US Regulatory)

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Thursday 31 October 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 4 October 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 4 October 2024 (4 months ago) • Edgar (US Regulatory)

More Leap Therapeutics Inc News Articles

Amarantus Bioscience (CE)

Meta Power (CE)

Artiva Biotherapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions